Saturday, October 31, 2026

SmileDirectClub Stock Is 11% Up So Far On Friday

ViaNews Editorial Team

August 11, 2023

SmileDirectClub Stock Is 11% Up So Far On Friday

SmileDirectClub (NASDAQ: SDC) experienced a noteworthy share surge of 11.27% as of 11:29 EST on Friday, reaching a trading price of $3.57 per share. This occurred despite its track record of four consecutive sessions of losses and amid overall decreases on the NASDAQ of 0.58%.

SDC's Current Trading Situation

On September 19th, SDC closed at $3.51, a figure that stands significantly below its 52-week high of $14.26, showcasing a significant fluctuation. Despite recent upward trends, SDC's trading price remains far from its annual peak.

About SmileDirectClub

SmileDirectClub is an internationally recognized company revered for their clear aligner therapy treatments. They also offer complementary oral care products across several countries. Their operations, from marketing to remote clinical monitoring, are efficiently facilitated through their innovative teledentistry platform, SmileCheck.

Financial Situation

In the past year, SmileDirectClub's quarterly revenue growth has suffered a 21% dip. This resulted in a trailing twelve-month revenue of $438.87 million, with an Earnings Per Share (EPS) of 2.628 - a possible sign of profitability issues. SmileDirectClub's Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) stands at -19.81, a metric investors often use to assess a company's operational performance.

SDC Share Performance

While SDC's stock has managed to stay above its 50- and 200-day moving averages at $3.50 and $3.53, this could suggest the early stages of an upward trend. However, market fluctuations should be closely monitored for a more precise evaluation of its performance.

Conclusion

Despite significant gains over time, SmileDirectClub shares remain comparatively low versus their 52-week high. The combination of decreasing revenue growth and negative EBITDA levels could raise investor concerns. However, surpassing moving averages may serve as an early indication that a recovery could be in the pipeline.

More news about SmileDirectClub (SDC).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com